Medicare Enrolled
Dr. Roland Reinhart, M.D.
Pain Medicine · Palm Desert, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reinhart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reinhart?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reinhart
Dr. Roland Reinhart is a pain medicine specialist in Palm Desert, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Reinhart performed 13,427 Medicare services across 3,079 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reinhart received a total of $77,893 from 52 pharmaceutical and/or device companies across 522 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reinhart is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in CA
$77,893 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,427
Medicare services
Top 3% in CA for pain medicine
3,079
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~707 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
6,920 | $0 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,046 | $100 | $315 |
| Contrast dye for imaging, lower concentration | 1,195 | $0 | $46 |
| Hymovis intra-articular injection An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space. |
393 | $13 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
249 | $137 | $424 |
| Annual depression screening | 228 | $20 | $25 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
190 | $222 | $950 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
145 | $95 | $250 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
136 | $53 | $550 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
127 | $66 | $189 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
111 | $219 | $934 |
| Injection, propofol, 10 mg | 111 | $0 | $7 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
80 | $221 | $900 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
80 | $199 | $836 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
75 | $97 | $540 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
52 | $135 | $568 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
47 | $99 | $475 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system. |
36 | $1,537 | $6,269 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
29 | $489 | $1,055 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $151 | $400 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
26 | $179 | $979 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
22 | $0 | $5 |
| Injection, fentanyl citrate, 0.1 mg | 19 | $1 | $12 |
| Spinal neurostimulator generator insertion Surgical placement of a spinal neurostimulator generator or receiver device. |
18 | $170 | $4,500 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
18 | $37 | $250 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $92 | $300 |
| Electronic analysis of implanted neurostimulator This procedure involves electronically analyzing an implanted neurostimulator generator and performing simple programming for spinal cord or peripheral nerve stimulation. |
15 | $40 | $100 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $108 | $726 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$77,893
Total received (2018-2024)
Avg $11,128/year across 7 years
Top 5% in CA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
522
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$46,200 (59.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,435 (21.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,258 (19.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,162
2023
$2,897
2022
$3,828
2021
$4,147
2020
$1,030
2019
$6,512
2018
$58,319
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$292
Nevro Corp.
$288
Boston Scientific Corporation
$166
Collegium Pharmaceutical, Inc.
$153
SPR Therapeutics, Inc
$73
Amgen Inc.
$69
DePuy Synthes Sales Inc.
$46
VERTEX PHARMACEUTICALS INCORPORATED
$31
Curonix LLC
$20
Saluda Medical Americas, Inc.
$18
Vertos Medical, Inc.
$6
Top 3 companies account for 64.2% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$47,485
INSYS Therapeutics Inc
$13,018
Nevro Corp.
$5,515
Vertos Medical, Inc.
$2,768
Spinal Simplicity, LLC
$2,592
Vertiflex, Inc.
$1,647
SPR Therapeutics, Inc
$616
Boston Scientific Corporation
$590
Collegium Pharmaceutical, Inc.
$559
Biohaven Pharmaceuticals, Inc.
$219
Medline Industries, Inc.
$216
Medtronic, Inc.
$204
Amgen Inc.
$191
FIDIA PHARMA USA INC.
$168
Intuitive Surgical, Inc.
$145
Pernix Therapeutics Holdings, Inc.
$142
Ziehm-Orthoscan, Inc.
$133
SI-BONE, Inc.
$127
BOSTON SCIENTIFIC CORPORATION
$125
Medtronic Vascular, Inc.
$100
Biogen, Inc.
$97
Seqirus USA Inc
$93
Daiichi Sankyo Inc.
$92
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$86
Fidia Pharma USA Inc.
$81
Biohaven Pharmaceutical Holding Company Ltd.
$75
West Therapeutics Development, LLC
$74
DePuy Synthes Sales Inc.
$65
Maxx Orthopedics, Inc.
$64
PAINTEQ LLC
$58
AstraZeneca Pharmaceuticals LP
$54
Scilex Pharmaceuticals Inc.
$51
SI-BONE, INC.
$34
VERTEX PHARMACEUTICALS INCORPORATED
$31
Stimwave Technologies Incorporated
$30
Almatica Pharma LLC
$30
Medtronic USA, Inc.
$29
ARBOR PHARMACEUTICALS, INC.
$29
Radius Health, Inc.
$26
Takeda Pharmaceuticals U.S.A., Inc.
$22
Lilly USA, LLC
$21
Eisai Inc.
$21
Curonix LLC
$20
Ortho Dermatologics, a division of Bausch Health US, LLC
$19
SCILEX PHARMACEUTICALS INC.
$19
Masimo Corporation
$18
Saluda Medical Americas, Inc.
$18
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$18
Arbor Pharmaceuticals, Inc.
$16
Novartis Pharmaceuticals Corporation
$16
Shionogi Inc
$15
RedHill Biopharma Inc.
$11
Top 3 companies account for 84.8% of all-time payments
Associated products mentioned in payments ›
Amitiza · Arctic Front · Axium INS DRG IPG · BELBUCA · Belbuca · CFNS StimQ Peripheral Nerve StimulatorSystem · DRG IPGs · Da Vinci Surgical System · EMGALITY · ETERNA · EVENITY · Evoke · Fluad · Freedom Total Knee System · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · HA MINUTEMAN G3-R · HYMOVIS · Horizant · Hymovis · INTELLIS · INTELLIS ADAPTIVESTIM · Lazanda · Leqembi · MONOVISC · MOVANTIK · Morphabond ER · Movantik · N'VISION · NURTEC ODT · Neuromodulation Dspsbls and Accs · OCTRODE · ORTHOVISC · Octrode SCS Leads · Omnia · PAINTEQ · PENTA · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Patient SafetyNet System · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · RELISTOR · SCS IPGs · SPRINT PNS System · SUBSYS · SUPERION · SYNDROS · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · Subsys · Superion · Superion ISS · Superion Indirect Decompression System · Symproic · Tymlos · Vanta · WaveWriter Alpha Prime 16 · XTAMPZA · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (59%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for pain medicine in CA.
Geographic Context
Pain medicines within 10 mi
7
Per 100K population
0.3
County median income
$89,672
Nearest hospital
EISENHOWER MEDICAL CENTER
4.8 mi
4.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reinhart is a clinical cardiology specialist, with above-average Medicare volume (top 3% in CA), with consulting-driven industry engagement in the top 5% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reinhart experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Reinhart performed 6,920 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reinhart receive payments from pharmaceutical companies?
Yes. Dr. Reinhart received a total of $77,893 from 52 companies across 522 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reinhart's costs compare to other pain medicines in Palm Desert?
Dr. Reinhart's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reinhart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Palm Desert
Browse pain medicines in Palm Desert ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in CA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in CA
Which CA pain medicines receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
INSYS Therapeutics Inc Payments to Doctors
See all physicians who received payments from INSYS Therapeutics Inc.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology